CD5 and acute lymphoblastic leukemia: CD5 CAR-NK cells, especially those constructed with the intracellular domain of NK-cell-associated activated receptor-2B4, exhibited specific cytotoxic properties against CD5+ malignant cells in vitro and remarkably prolonged the survival of T-ALL xenograft mice in vivo.